PNLIP and neoplasm: PTL uniquely regulates tumor stem cells, selectively targets tumor microenvironments, and demonstrates compatibility with the CMD‐BHQ3 delivery system.[37] By inhibiting tumor stem cell activity, PTL disrupts cancer cell hierarchies, enhancing therapeutic efficacy.